nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apnea and its possible relationship to immunization in ex-premature infants
|
Cooper, Peter A. |
|
2008 |
26 |
27-28 |
p. 3410-3413 4 p. |
artikel |
2 |
Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice
|
Pasquali, Paolo |
|
2008 |
26 |
27-28 |
p. 3421-3426 6 p. |
artikel |
3 |
Can schistosomiasis really be consigned to history without a vaccine?
|
Bethony, Jeffrey M. |
|
2008 |
26 |
27-28 |
p. 3373-3376 4 p. |
artikel |
4 |
Cloning, expression and evaluation of the efficacy of a recombinant Eimeria tenella sporozoite antigen in birds
|
Mohana Subramanian, B. |
|
2008 |
26 |
27-28 |
p. 3489-3496 8 p. |
artikel |
5 |
Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum
|
Xie, Yong |
|
2008 |
26 |
27-28 |
p. 3452-3460 9 p. |
artikel |
6 |
Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
|
Denis, Jérôme |
|
2008 |
26 |
27-28 |
p. 3395-3403 9 p. |
artikel |
7 |
Editorial Board
|
|
|
2008 |
26 |
27-28 |
p. CO2- 1 p. |
artikel |
8 |
Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection
|
Parida, S. |
|
2008 |
26 |
27-28 |
p. 3469-3479 11 p. |
artikel |
9 |
Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the “Protection against Podal Generalisation” test
|
Goris, N. |
|
2008 |
26 |
27-28 |
p. 3432-3437 6 p. |
artikel |
10 |
HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination
|
Lin, Hans Hsienhong |
|
2008 |
26 |
27-28 |
p. 3414-3420 7 p. |
artikel |
11 |
Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale
|
Kano, Flora S. |
|
2008 |
26 |
27-28 |
p. 3522-3527 6 p. |
artikel |
12 |
Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S. Army trainees, 2002–2006
|
Lee, Seung-eun |
|
2008 |
26 |
27-28 |
p. 3383-3386 4 p. |
artikel |
13 |
Invasive Pneumococcal disease in Singapore children
|
Chong, Chia-Yin |
|
2008 |
26 |
27-28 |
p. 3427-3431 5 p. |
artikel |
14 |
Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: Application to World Health Organization measles aerosol project
|
Cohen, B.J. |
|
2008 |
26 |
27-28 |
p. 3534-3539 6 p. |
artikel |
15 |
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
|
Fine, Donald L. |
|
2008 |
26 |
27-28 |
p. 3497-3506 10 p. |
artikel |
16 |
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
|
Taylor, Claribel P. |
|
2008 |
26 |
27-28 |
p. 3404-3409 6 p. |
artikel |
17 |
Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B
|
Dutta, Tathagata |
|
2008 |
26 |
27-28 |
p. 3389-3394 6 p. |
artikel |
18 |
Prediction of pertussis vaccine efficacy using a correlates of protection model
|
Kohberger, Robert C. |
|
2008 |
26 |
27-28 |
p. 3516-3521 6 p. |
artikel |
19 |
Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture
|
Yang, Ming |
|
2008 |
26 |
27-28 |
p. 3377-3382 6 p. |
artikel |
20 |
Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults
|
Roukens, A.H. |
|
2008 |
26 |
27-28 |
p. 3438-3442 5 p. |
artikel |
21 |
Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2
|
Kixmöller, Marion |
|
2008 |
26 |
27-28 |
p. 3443-3451 9 p. |
artikel |
22 |
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections
|
Zhan, Xiaoyan |
|
2008 |
26 |
27-28 |
p. 3480-3488 9 p. |
artikel |
23 |
Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine
|
Gelinck, L.B.S. |
|
2008 |
26 |
27-28 |
p. 3528-3533 6 p. |
artikel |
24 |
Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies
|
Golden, Joseph W. |
|
2008 |
26 |
27-28 |
p. 3507-3515 9 p. |
artikel |
25 |
The effectiveness of varicella vaccination during an outbreak in a childrens’ day-care center
|
Kiliç, Ayşe |
|
2008 |
26 |
27-28 |
p. 3371-3372 2 p. |
artikel |
26 |
The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice
|
Riedl, Karin |
|
2008 |
26 |
27-28 |
p. 3461-3468 8 p. |
artikel |
27 |
Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
|
Toomey, Deirdre |
|
2008 |
26 |
27-28 |
p. 3540-3549 10 p. |
artikel |
28 |
Vaccine with herbal adjuvant—A better cocktail to combat the infection
|
Sakure, Sandhya |
|
2008 |
26 |
27-28 |
p. 3387-3388 2 p. |
artikel |